# Nancy A. Mason

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/nancy-a-mason/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,186 |
| Field | Pharmaceutical Practices and Patient Outcomes |
| h-index | 24 |
| i10-index | 36 |
| Last Known Institution | Massachusetts General Hospital |
| OpenAlex ID | https://openalex.org/A5112578603 |
| Works | 69 |

## Researcher papers

- [Screening for depression in hemodialysis patients: Associations with diagnosis, treatment, and outcomes in the DOPPS](https://scholariq.org/papers/screening-for-depression-in-hemodialysis-patients-associations-with-diagnosis/)
- [Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality](https://scholariq.org/papers/data-from-the-dialysis-outcomes-and-practice-patterns-study-validate-an/)
- [HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients](https://scholariq.org/papers/hmg-coenzyme-a-reductase-inhibitor-use-is-associated-with-mortality-reduction-in/)
- [Diuretic Use, Residual Renal Function, and Mortality Among Hemodialysis Patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS)](https://scholariq.org/papers/diuretic-use-residual-renal-function-and-mortality-among-hemodialysis-patients/)
- [Parenteral iron use in the management of anemia in end-stage renal disease patients](https://scholariq.org/papers/parenteral-iron-use-in-the-management-of-anemia-in-end-stage-renal-disease/)
- [Aspirin Prescription and Outcomes in Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS)](https://scholariq.org/papers/aspirin-prescription-and-outcomes-in-hemodialysis-patients-the-dialysis-outcomes/)
- [Polypharmacy and medication-related complications in the chronic kidney disease patient](https://scholariq.org/papers/polypharmacy-and-medication-related-complications-in-the-chronic-kidney-disease/)
- [Analgesic prescription patterns among hemodialysis patients in the DOPPS: Potential for underprescription](https://scholariq.org/papers/analgesic-prescription-patterns-among-hemodialysis-patients-in-the-dopps/)
- [Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS](https://scholariq.org/papers/prescription-of-antihypertensive-agents-to-haemodialysis-patients-time-trends/)
- [Chronic Hemodialysis Patients. Part I: Characterization and Drug-Related Problems](https://scholariq.org/papers/chronic-hemodialysis-patients-part-i-characterization-and-drug-related-problems/)

## Researcher topics

- [Pharmaceutical Practices and Patient Outcomes](https://scholariq.org/topics/pharmaceutical-practices-and-patient-outcomes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Palliative Care and End-of-Life Issues](https://scholariq.org/topics/palliative-care-and-end-of-life-issues/)
- [Nursing education and management](https://scholariq.org/topics/nursing-education-and-management/)

## Researcher university

- [Massachusetts General Hospital](https://scholariq.org/institutions/massachusetts-general-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.